6. The following laboratory results within 14 days prior to study drug administration: Adequate hematopoietic, electrolyte, hepatic, and renal laboratory findings as defined below: White Blood Cells (WBC) ≥ 3000/μL, Neutrophils ≥ 1500/μL, Platelets ≥ 100x103/μL, Hemoglobin ≥ 9.0 g/dL, Creatinine ≤ 1.5 mg/dL, Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) ≤ 3 x ULN, Alkaline phosphatase ≤ 2.5 x Upper Limit of Normal (ULN) unless bone metastases present, Bilirubin ≤ 1.5 x ULN (unless known Gilbert's disease where it must be ≤3xULN)